Top 5 Biotech Startup Investors in Isle of Man in September 2024
A list of 5 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Isle of man. We rank investors based on the number of investments they made in Biotech companies from Isle of man. We update this investor list every month.Top 5 Biotech Startup Investors in Isle of Man in September 2024
Investor | Biotech Isle of Man investments |
---|---|
Jim Mellon | 1 |
Andrew Banks | 1 |
Juvenescence | 1 |
Greg Bailey | 1 |
Foresite Capital | 1 |
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more
Investment focus
- Biotechnology, Health Care, Food and Beverage
- Series A, Seed, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Andrew Banks - Chairman and Co-Founder @ ABRY Partners
Show more
Investment focus
- Biopharma, Biotechnology, Pharmaceutical
- Seed
- Isle of Man
Portfolio highlights
- Juvenescence — Juvenescence is extending healthy human lifespan through aging research, development of therapies to counter age-related diseases & our ketone ester drink, Metabolic Switch.
Juvenescence is extending healthy human lifespan through aging research, development of therapies to counter age-related diseases & our ketone ester drink, Metabolic Switch.
Show more
Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Funding Round, Series A, Debt Financing
- United States, Hong Kong, Isle of Man
Portfolio highlights
- LyGenesis — LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
- MDI Therapeutics — MDI Therapeutics is an operator of a discovery stage company focused on developing novel therapies for fibrotic diseases. The company have developed a proprietary discovery platform which has successfully identified novel small molecule and protein drug candidates, and have advanced these programs through key translational experiments usingclinical biomarkers.
- Souvien Therapeutics — Souvien Therapeutics is a biotechnology company focused on developing therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.
Dr. Gregory H. Bailey is a Managing Partner at Palantir Group, Inc. Dr. Bailey is the Co-founder of Ascent Healthcare Solutions; VirnetX Inc. (AMEX:VHC) and Duramedic Inc. He was also the initial public financier and an independent director of Medivation, Inc. (NASDAQ:MDVN), from 2005 to December 2012. Dr. Bailey served as the Managing Director andco-Head of Life Sciences at MDB Capital Group LLC from May 2004 to January 2007. Previously he served as Life Sciences Analyst at Participating Capital, Corp. He has served on the board of directors of multiple public companies. Dr. Bailey has Medical Doctorate from the University of Western Ontario and practiced medicine as an emergency physician for ten years.
Show more
Investment focus
- Biotechnology, Pharmaceutical, Medical
- Seed, Series A, Funding Round
- United States, Isle of Man
Portfolio highlights
- Juvenescence — Juvenescence is extending healthy human lifespan through aging research, development of therapies to counter age-related diseases & our ketone ester drink, Metabolic Switch.
- Bristol-Myers Squibb — Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
- Biohaven Pharmaceutical — Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipelineproducts include BHV3000-301, BHV3000-302, BHV3000-303, and others.
We are a multi-stage investment firm, investing in companies that leverage biology and big data to transform healthcare.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series C, Series A
- United States, United Kingdom, Australia
Portfolio highlights
- Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
- Element Biosciences — Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high quality data, workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietaryapproach to improve the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality.
- Foresight Diagnostics — Breakthrough cancer diagnostics. Next-level clinical outcomes. Foresight Diagnostics develops and delivers innovative diagnostic tests that combine precisio ...
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Media (entertainment)
Proptech
Marketplace
Community
FinTech
Google
EdTech
Agriculture (agtech)
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Consumer
Biotech
Social Media
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Medical
Education
Payments
Fashion
Organic Food
Retail
Financial Services
Infrastructure
Platforms
Mobile Advertising
Biotechnology
Hospitality
Fitness
Email
Art
Wellness
Music
Mobile
Franchise
Social Network
Local
Internet
Digital Media
Construction
Manufacturing
eSports
Sports
Enterprise Software
Legal
Android
Wine And Spirits
Medical Device
Crowdfunding
Social
Travel
Recruiting
Cannabis
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Automotive
Restaurants
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Software
Social Impact
Cryptocurrency
Celebrity
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Czech Republic
Ecuador
Barbados
Armenia
Costa Rica
Finland
Vietnam
Belarus
France
Estonia
Hong Kong
China
Japan
Saudi Arabia
Denmark
Brazil
Gibraltar
Chile
Oceania
Bermuda
Belize
Georgia
Greece
Morocco
Egypt
Hungary
Malta
Mali
Ethiopia
Faroe Islands
Algeria
Ghana
Malaysia
Belgium
Croatia
Bulgaria
Bahrain
Turkey
Serbia
Rwanda
Italy
El Salvador
Venezuela
Ukraine
Peru
Portugal
Lithuania
Sierra Leone
Zimbabwe
Sweden
Myanmar
Taiwan
Lebanon
Senegal
Kuwait
Cayman Islands
Uruguay
Uganda
Tunisia
Cambodia
Israel
San Marino
Slovenia
Panama
Zambia
Uzbekistan
Russian Federation
Mexico
Seychelles
Thailand
Kazakhstan
Liberia
Puerto Rico
Jersey
Philippines
Tajikistan
Togo
Poland
Tanzania
Norway
Dominican Republic
Nigeria
Azerbaijan
Namibia
Iceland
Mauritius
Iraq
Bahamas
United Arab Emirates
Kenya
Honduras
Bolivia
Isle of Man
Liechtenstein
Luxembourg
Nicaragua
Albania
Pakistan
Latvia
Grenada
Jordan
Romania
Argentina
Bangladesh
Cyprus
Oman
Austria
Cameroon
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Isle of Man by industry